C69.40
Malignant neoplasm of unspecified ciliary body
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm of the ciliary body is a rare type of eye cancer that begins in the ciliary body, a part of the eye located behind the iris and in front of the retina. When the specific location within the ciliary body isn’t precisely identified, it is classified under the ICD-10 code C69.40. This condition can affect vision and eye health and requires careful diagnosis and management. Understanding the nature of this disease can help patients and caregivers recognize signs and seek appropriate medical attention.
Causes & Symptoms
Clinical Causes: Genetic factors that predispose individuals to ocular tumors Certain inherited cancer syndromes History of radiation exposure to the eye region Pediatric cases linked to hereditary conditions Rare mutations in genes involved in cellular growth regulation
Key Symptoms: Visual disturbances such as blurred vision or sudden vision loss Appearance of a shadow or floaters in the visual field Visible change in the eye's appearance, sometimes with a noticeable mass Eye pain or discomfort in more advanced stages Unexplained redness or swelling in the eye Persistent irritation or irritation that does not improve
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves comprehensive ophthalmologic examination, including slit-lamp inspection and imaging studies such as ultrasound biomicroscopy, MRI, or CT scans to visualize the tumor. Biopsy may be performed to confirm malignancy. A detailed medical history and assessment of symptoms are also important for accurate diagnosis. The extent of the tumor and its possible spread are assessed to determine the appropriate treatment course.
Treatment Protocols: Treatment options depend on the tumor size, location, and spread but may include: - Surgical removal of the tumor or affected eye in severe cases - Radiation therapy to target and destroy cancer cells - Chemotherapy, sometimes used in conjunction with other treatments - Plaque brachytherapy, a localized form of radiation - Regular follow-up to monitor for recurrence or progression Early detection and intervention are crucial for preserving eye function and overall health, emphasizing the importance of prompt medical evaluation for symptoms suggestive of ocular tumors.
Clinical Advice & FAQs
Billing Guidance
Is C69.40 a billable ICD-10 code?
Yes, C69.40 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C69.40?
Clinical documentation must specify the nature of Malignant neoplasm of unspecified ciliary body and any associated comorbidities for accurate reporting.
Cite this Clinical Reference